User talk:Eg1798a

Ref
New treatment methods using dopamine and somatostatin are currently being explored. Recent studies have shown that somatostatin receptor subtype 5 and dopamine receptor subtype 2 are frequently co-expressed by corticotroph adenomas (the most common cause of Cushing's disease in both humans and canines). This suggests possible functional interactions in the control of hormonal hypersecretion and tumor growth. Chimeric compounds of the receptors are currently being explored as an option to reduce ACTH levels.

THe ref does not work.

Also please read WP:MEDRS Doc James  (talk · contribs · email) 04:24, 23 November 2015 (UTC)